Add this result to my export selection Medicines Identified as Low Priority for Funding in NHS Wales – Paper 2 Source: All Wales Medicines Strategy Group - AWMSG (Remove filter) Published by All Wales Medicines Strategy Group (AWMSG), 01 December 2018 Four medicines/medicine groups have been identified for the purposes of this document: omega-3 fatty acid compounds, oxycodone and naloxone combination product, paracetamol and tramadol combination... Read Summary Type: Prescribing and Technical Information (Remove filter)
Add this result to my export selection All Wales guidance on prescribing for erectile dysfunction Source: All Wales Medicines Strategy Group - AWMSG (Remove filter) Published by All Wales Medicines Strategy Group (AWMSG), 30 September 2012 This revised guidance removes the restriction of specialist assessment and review, enabling GPs to prescribe where appropriate. It also recommends Health Boards put in place clearly defined... Read Summary Type: Prescribing and Technical Information (Remove filter)
Add this result to my export selection Prescribing of low molecular weight heparin in Wales Source: All Wales Medicines Strategy Group - AWMSG (Remove filter) Published by All Wales Medicines Strategy Group (AWMSG), 01 September 2016 This paper recommendations and further actions for prescribing of low molecular weight heparin. Read Summary Type: Prescribing and Technical Information (Remove filter)
Add this result to my export selection Prescribing of Denosumab (Prolia®) in Wales: Review Source: All Wales Medicines Strategy Group - AWMSG (Remove filter) Published by All Wales Medicines Strategy Group (AWMSG), 01 October 2013 This paper outlines the recommendations and guidance relating to the prescribing in Wales of denosumab (Prolia) for the prevention of osteoporotic fractures in postmenopausal women. Read Summary Type: Prescribing and Technical Information (Remove filter)
Add this result to my export selection Warfarin monitoring Source: All Wales Medicines Strategy Group - AWMSG (Remove filter) Published by All Wales Medicines Strategy Group (AWMSG), 19 June 2012 This paper provides recommendation for best practice in relation to the monitoring of warfarin therapy in Wales. Read Summary Type: Prescribing and Technical Information (Remove filter)
Add this result to my export selection All Wales prescribing guidelines : initiating contraception in primary care Source: All Wales Medicines Strategy Group - AWMSG (Remove filter) Published by All Wales Medicines Strategy Group (AWMSG), 11 September 2012 Prescribing guidelines for contraception initiation in primary care have been developed by the All Wales Prescribing Advisory Group based on work by NHS Greater Glasgow and Clyde in order to reduce... Read Summary Type: Prescribing and Technical Information (Remove filter)
Add this result to my export selection All Wales COPD Management and Prescribing Guideline Source: All Wales Medicines Strategy Group - AWMSG (Remove filter) Published by All Wales Medicines Strategy Group (AWMSG), 01 August 2020 All Wales COPD Management and Prescribing Guideline Minor update: August 2020 update: This document has been updated to reflect the change in strength of the Anoro Ellipta inhaler from ‘62.5/25’ ... Read Summary Type: Prescribing and Technical Information (Remove filter)
Add this result to my export selection Endocrine Management of Gender Dysphoria in Adults Prescribing Guidance: Prescribing Guidance for Non-specialist Practitioners Source: All Wales Medicines Strategy Group - AWMSG (Remove filter) Published by All Wales Medicines Strategy Group (AWMSG), 13 November 2019 This document is intended for non-specialist practitioners engaged in the prescribing and monitoring of medical therapies used in the management of gender dysphoria.* Read Summary Type: Prescribing and Technical Information (Remove filter)
Add this result to my export selection Persistent pain resources: Medicines used in persistent pain Source: All Wales Medicines Strategy Group - AWMSG (Remove filter) Published by All Wales Medicines Strategy Group (AWMSG), 01 October 2016 A review of medicines commonly used in the treatment of persistent pain, such as tramadol, gabapentin, pregabalin, and fentanyl and buprenorphine patches, and their prescribing, with particular... Read Summary Type: Prescribing and Technical Information (Remove filter)
Add this result to my export selection Safeguarding users of opioid patches by standardising patient/caregiver counselling Source: All Wales Medicines Strategy Group - AWMSG (Remove filter) Published by All Wales Medicines Strategy Group (AWMSG), 01 September 2016 (Minor update to include information on co-sleeping made in August 2018) The aim of the counselling checklist is to assist healthcare professionals, working in community pharmacies, primary care... Read Summary Type: Prescribing and Technical Information (Remove filter)